1.Interleukin-1 gene polymorphism disease activity and bone mineral metabolism in rheumatoid arthritis.
Xiao ZHANG ; L LLAMADO ; I PILLAY ; P PRICE ; R WILL
Chinese Medical Journal 2002;115(1):46-49
<p>OBJECTIVETo determine whether interleukin-1 alpha and 1 beta gene polymorphism is associated with rheumatoid arthritis disease activity and bone mineral metabolism, and whether there is any relationship between IL-1 beta and rheumatoid arthritis (RA) motif gene.p><p>METHODSIL-1 gene polymorphisms were analyzed in 65 RA patients who met American College of Radiology (ACR) criteria and 60 controls. From genomic DNA, 2 polymorphisms in each gene for IL1 alpha-889 and IL-1 beta + 3953 were typed by PCR-RFLP and HLA-DRB1 allele typing was also undertaken by PCR-SSOP. Some clinical and laboratory parameters were collected. The allelic frequencies and carriage rates were compared between RA patients and controls and between patients with active and quiescent disease. Comparison was also made between IL-1 polymorphism and parameters of bone mineral metabolism and between patients with the HLA-DRB1 RA motif plus IL-1 beta 2 and patients without the two alleles. Fisher test and the analysis of variance was used to analyze the data.p><p>RESULTSThere was no significant difference in the frequency and carriage rate of IL-1 alpha polymorphisms between RA patients and the controls. The beta 2/2 genotype of IL-1 beta was more common in female RA patients compared with controls (P = 0.001). A lower carriage rate of IL-1 beta 2 occurred in male RA patients (P = 0.001). A higher carriage rate of IL-1 alpha 2 is associated with a higher ESR (P = 0.008), HAQ score (P = 0.03), and vit-D3 (P < 0.001), but conversely a lower SJC (p = 0.002), a lower RF (P = 0.002) and a lower BMD at the lumbar spine (P = 0.001). A higher frequency of IL-1 alpha 1 is associated with a lower CRP value (P = 0.009). An increased IL-1 beta 2 carriage is associated with active rheumatoid disease as indicated by a higher CRP (P < 0.001), ESR (P < 0.001) and pain score (P = 0.001) and a higher BMD at the lumbar spine (P = 0.007), lower vit-D3 and. Udpd/Crea level The presence of the HLA DRB1 RA motif and IL-1 beta allele 2 at same time did not contribute to disease activity.p><p>CONCLUSIONPolymorphisms of the IL-beta gene may affect the RA occurrence. Carriage of IL-1 beta 2 polymorphisms is associated with more active disease in RA and the presence of both the IL-1 alpha 2 and the IL-1 beta 1 allele in RA influences bone resorption.p>
Alleles
;
Arthritis, Rheumatoid
;
genetics
;
metabolism
;
Bone Density
;
Female
;
HLA-DR Antigens
;
genetics
;
HLA-DRB1 Chains
;
Humans
;
Interleukin-1
;
genetics
;
Male
;
Polymorphism, Genetic
2.Characterization of the tunicamycin gene cluster unveiling unique steps involved in its biosynthesis.
Wenqing CHEN ; Dongjing QU ; Lipeng ZHAI ; Meifeng TAO ; Yemin WANG ; Shuangjun LIN ; Neil P J PRICE ; Zixin DENG
Protein & Cell 2010;1(12):1093-1105
Tunicamycin, a potent reversible translocase I inhibitor, is produced by several Actinomycetes species. The tunicamycin structure is highly unusual, and contains an 11-carbon dialdose sugar and an α, β-1″,11'-glycosidic linkage. Here we report the identification of a gene cluster essential for tunicamycin biosynthesis by high-throughput heterologous expression (HHE) strategy combined with a bioassay. Introduction of the genes into heterologous non-producing Streptomyces hosts results in production of tunicamycin by these strains, demonstrating the role of the genes for the biosynthesis of tunicamycins. Gene disruption experiments coupled with bioinformatic analysis revealed that the tunicamycin gene cluster is minimally composed of 12 genes (tunA-tunL). Amongst these is a putative radical SAM enzyme (Tun B) with a potentially unique role in biosynthetic carbon-carbon bond formation. Hence, a seven-step novel pathway is proposed for tunicamycin biosynthesis. Moreover, two gene clusters for the potential biosynthesis of tunicamycin-like antibiotics were also identified in Streptomyces clavuligerus ATCC 27064 and Actinosynnema mirums DSM 43827. These data provide clarification of the novel mechanisms for tunicamycin biosynthesis, and for the generation of new-designer tunicamycin analogs with selective/enhanced bioactivity via combinatorial biosynthesis strategies.
Actinobacteria
;
enzymology
;
genetics
;
Base Sequence
;
Biological Assay
;
Carbohydrate Sequence
;
Carbohydrates
;
biosynthesis
;
genetics
;
Cloning, Molecular
;
Gene Deletion
;
Gene Library
;
High-Throughput Screening Assays
;
Molecular Sequence Data
;
Multigene Family
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
Sequence Analysis, DNA
;
Streptomyces
;
enzymology
;
genetics
;
Tunicamycin
;
biosynthesis
;
chemistry
;
genetics